Hence, the inclusion of fusion receptors such as interleukin (IL)‐4–IL‐7 chimeric cytokine receptors has the propensity to shift the inhibitory signals from IL‐4 to IL‐7 signalling – leading to proliferation and memory differentiation of T cells at the tumor site.155. This evidence concerns the gene IL7 and neoplasm.